The Chemours Company (NYSE:CC) SVP Alvenia Scarborough Sells 7,500 Shares

The Chemours Company (NYSE:CC) SVP Alvenia Scarborough sold 7,500 shares of Chemours stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $20.64, for a total transaction of $154,800.00. Following the transaction, the senior vice president now directly owns 16,645 shares in the company, valued at $343,552.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Chemours Trading Down 2.6 %

CC stock opened at $19.29 on Wednesday. The firm has a fifty day moving average price of $19.06 and a 200 day moving average price of $21.90. The Chemours Company has a fifty-two week low of $15.10 and a fifty-two week high of $32.70. The firm has a market cap of $2.88 billion, a PE ratio of 38.58 and a beta of 1.75. The company has a debt-to-equity ratio of 6.05, a quick ratio of 1.01 and a current ratio of 1.73.

Chemours (NYSE:CC) last issued its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $0.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.32 by $0.08. The business had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.44 billion. Chemours had a return on equity of 29.48% and a net margin of 1.34%. The company’s quarterly revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.64 earnings per share. Sell-side analysts anticipate that The Chemours Company will post 1.35 earnings per share for the current fiscal year.

Chemours Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 5.18%. The ex-dividend date of this dividend is Friday, November 15th. Chemours’s payout ratio is currently 200.00%.

Wall Street Analysts Forecast Growth

CC has been the topic of several recent analyst reports. UBS Group decreased their price objective on shares of Chemours from $30.00 to $28.00 and set a “buy” rating on the stock in a research report on Tuesday, August 6th. Royal Bank of Canada dropped their price target on Chemours from $28.00 to $25.00 and set an “outperform” rating for the company in a research note on Wednesday, November 6th. Morgan Stanley cut their price objective on shares of Chemours from $30.00 to $25.00 and set an “equal weight” rating for the company in a report on Tuesday, November 5th. Barclays boosted their target price on shares of Chemours from $21.00 to $23.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. Finally, The Goldman Sachs Group cut their target price on shares of Chemours from $29.00 to $23.00 and set a “neutral” rating for the company in a research note on Tuesday, September 3rd. Five investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Chemours has a consensus rating of “Hold” and an average target price of $24.88.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of CC. Matrix Trust Co purchased a new stake in shares of Chemours during the third quarter valued at $25,000. Blue Trust Inc. increased its position in shares of Chemours by 166.9% during the third quarter. Blue Trust Inc. now owns 1,169 shares of the specialty chemicals company’s stock worth $26,000 after acquiring an additional 731 shares during the period. New Covenant Trust Company N.A. purchased a new stake in shares of Chemours in the first quarter valued at approximately $29,000. Signaturefd LLC grew its stake in Chemours by 163.7% in the third quarter. Signaturefd LLC now owns 1,959 shares of the specialty chemicals company’s stock worth $40,000 after purchasing an additional 1,216 shares in the last quarter. Finally, Headlands Technologies LLC purchased a new position in Chemours during the 1st quarter worth $42,000. Institutional investors own 76.26% of the company’s stock.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.